在慢性阻塞性睡眠呼吸暂停的老鼠模型中,JAK1-STAT1信号通路触发了炎症反应
1Department of Pulmonary and Critical Care Medicine, Huili People's Hospital, Liangshan Yi Autonomous Prefecture, Huili, Sichuan, China.
在阻塞性睡眠呼吸暂停 (OSA) 中,慢性间歇性缺氧 (CIH) 激活了JAK1-STAT1通路,导致炎症. 抑制JAK1降低了炎症并改善了呼吸道功能,这表明OSA的治疗点.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 与全身炎症有关.
- 在OSA相关的炎症中,Janus酶1-信号转换器和转录1 (JAK1-STAT1) 途径激活器的特定作用需要澄清.
研究的目的:
- 调查JAK1-STAT1通路在由慢性间歇性缺氧 (CIH) 诱导的炎症中的参与,这是OSA的一个模型.
- 评估JAK1抑制在缓解CIH诱导的炎症反应中的治疗潜力.
主要方法:
- 大鼠接受了8周的CIH或normoxia (Sham) 治疗.
- 测量了血清细胞因子水平 (IL-6,TNF-α) 和肺部p-JAK1/p-STAT1表达.
- 一种JAK1抑制剂filgotinib被给予CIH大鼠的一个子集.
- 使用强制振荡技术评估了气道阻力.
主要成果:
- 与Sham相比,CIH显著增加了血清IL-6和TNF-α水平,并增加了肺中的p-JAK1/p-STAT1表达.
- 菲尔戈提尼布治疗降低了细胞因子水平,抑制了JAK1-STAT1酸化,减弱了白细胞透和肺部原沉积,改善了呼吸道抵抗力.
- 肺部p-STAT1水平与血清IL-6和TNF-α度具有强烈的正相关性.
结论:
- JAK1-STAT1信号通路在调解慢性间歇性缺氧引起的炎症方面发挥着关键作用.
- 在CIH模型中,JAK1抑制有效减轻炎症反应并改善生理参数.
- 向JAK1是一个有希望的治疗策略,用于管理与阻塞性睡眠呼吸暂停并发症相关的炎症.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
05:45Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
Published on: October 25, 2019
相关概念视频
The JAK-STAT Signaling Pathway
Sleep Apnea
The condition is more prevalent among...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
MAPK Signaling Cascades
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
